glp-1 microdosing perimenopause Weight Gain During Menopause: Solutions in the Era of GLP1-agonists Let’s talk about GLP-1 medications

Skrha et al

The resulting energy deficit manifests clinically as debilitating fatigue and post-exertional malaise (PEM), hallmark symptoms of both Long COVID and ME/CFS

TB-500, wound healing

Comorbidities can also cut the other way

Forms with generally good tolerability include: Magnesium glycinate : Chelated to the amino acid glycine, this form demonstrates good absorption and minimal laxative effect, making it potentially suitable for GLP-1 users already experiencing gastrointestinal symptoms

Studies suggest that patients benefit most when treatment is paired with practical, personalized nutrition support that adapts over time